GlassScriptPhysician profile
William D Gibson
NPI 1316977812
$531.08
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $180 · 2022: $96.21 · 2023: $120 · 2024: $14.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $121.15 | 2019 | |
| Allergan, INC. | $112.09 | 2021 | |
| Pfizer INC. | $66.95 | 2021-2022 | |
| Vapotherm INC | $37.31 | 2022 | |
| Novo Nordisk INC | $36.21 | 2023 | Wegovy |
| Sobi, INC | $28.11 | 2022 | |
| Lsi Solutions INC | $20.21 | 2023 | Fornisee |
| Alpha Orthopedic Systems | $17.21 | 2023 | |
| Exact Sciences Corporation | $16.13 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $15.86 | 2022 | |
| Integra Lifesciences Corporation | $15.84 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Glaxosmithkline, LLC. | $15.68 | 2021 | |
| Organogenesis INC. | $14.21 | 2024 | Novachor |
| Organon LLC | $14.12 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gibson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.